Thermo Fisher Scientific

New Dionex Easion IC System Offers Preconfigured Kits for Analysis
Test & Measurement

New Dionex Easion IC System Offers Preconfigured Kits for Analysis

Equipped to run out of the box, including columns, suppressor and consumable items required to perform IC separations. Brings an advanced level of simplicity to anion and cation analyses of drinking water. Encompasses a single-flow path, simplifying both operation and maintenance, which frees laboratory workers' time to focus on sample analysis, instead of system setup and optimization.

Read More »
New Helios 5 PFIBs Ion Beam Scanning Electron Microscopes Provide Scientists with Higher Throughput and Higher Quality Characterization
Optics & Photonics

New Helios 5 PFIBs Ion Beam Scanning Electron Microscopes Provide Scientists with Higher Throughput and Higher Quality Characterization

Offer faster, easier, and more precise sample preparation and higher-quality subsurface and 3D analysis for the widest range of materials and biological samples. Allow materials scientists to discover and design new materials and analyze their structures and properties. Suitable for labs that conduct both materials and life science research.

Read More »
New nProber IV Platform Offers Fast Identification of Defects
Laboratory and Research Supplies and Equipment

New nProber IV Platform Offers Fast Identification of Defects

Provides specific localization and accurate electrical characterization of parametric faults in advanced FinFET transistors. Delivers good levels of automation and precision for semiconductor yield engineers as they perform leading-edge and mid-range logic and memory failure analysis. EBIRCH2 fault localization is combined with the LEEN2 SEM column that can operate at up to 100 nA.

Read More »
Company News

Thermo Fisher Scientific Completes FDA Listing and Launches The Applied Biosystems QuantStudio 5 Dx Real-time PCR System for in Vitro Diagnostic Use

Innovative qPCR platform simplifies molecular diagnostic workflows for infectious disease, oncology and COVID-19 testing Carlsbad, Calif., March 25, 2021 /PRNewswire/ -- Thermo Fisher Scientific today announced the completion of the U.S. Food and Drug Administration (FDA) listing for the Applied Biosystems QuantStudio 5 Dx Real-Time PCR System. The innovative product enables clinical...

Read More »
Company News

Thermo Fisher Scientific Investments Support Rapidly Increasing Bioprocessing Production

More than $600 million in investments will enable reliable supply of critical materials used to produce new vaccines and biologics WALTHAM, Mass., March 10, 2021 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, today announced more than $600 million in capital investments to expand its bioprocessing production capabilities through 2022. These...

Read More »
Mergers & Acquisitions

Thermo Fisher Scientific Completes Acquisition of Mesa Biotech

WALTHAM, Mass., Feb. 26, 2021 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced it has completed its previously announced acquisition of Mesa Biotech, Inc., a privately held point-of-care molecular diagnostic company. "Mesa Biotech is an important part of our strategy to expand the benefits of molecular diagnostics at the point of...

Read More »
Company News

Thermo Fisher Scientific Announces Oncomine Clinical Research Grant 2021 Call for Submissions

Carlsbad, Calif., Feb. 23, 2021 /PRNewswire/ -- Thermo Fisher Scientific has opened a call for submissions for its Oncomine Clinical Research Grant program to support clinical research. The program aims to assist educational and independent research projects that exhibit excellence in molecular profiling to advance clinical outcomes and support health care providers serving cancer patients....

Read More »
Company News

Thermo Fisher Scientific and Innoforce Partner to Establish Biologics and Steriles Drug Manufacturing Facility in China

Joint venture expands global pharma services capacity for drug development and manufacturing WALTHAM, Mass. and SHANGHAI, Nov. 6, 2020 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, and Innoforce, a bioinnovation-enabling company, today announced they have signed a joint venture agreement to establish a new pharma services facility...

Read More »

All Topics